{"name":"Qingfeng Pharmaceutical Group","slug":"qingfeng-pharmaceutical-group","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Amoxicillin-clavulantic acid","genericName":"Amoxicillin-clavulantic acid","slug":"amoxicillin-clavulantic-acid","indication":"Other","status":"marketed"},{"name":"Azithromycin, Minocycline or Doxycycline","genericName":"Azithromycin, Minocycline or Doxycycline","slug":"azithromycin-minocycline-or-doxycycline","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Amoxicillin-clavulantic acid","genericName":"Amoxicillin-clavulantic acid","slug":"amoxicillin-clavulantic-acid","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Azithromycin, Minocycline or Doxycycline","genericName":"Azithromycin, Minocycline or Doxycycline","slug":"azithromycin-minocycline-or-doxycycline","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNVXpCV25oMmg5aTBBVVZ2cGd1OG9aLUR0aTJJQ2ZHeXQ2TWdHU0gweVlLZ2dXbmVhLXlCaG55X1d2M18yT1J2bk5QbEtXY0JoYWZtbmVrWV96MHVBcW4yOWNaMDhVbWtDTGh1Vkc1UG05em1PaGhVYVRpcFZmbUhCaXBYVU5NcGNXbGljY29fSVUwTzhabmUzSDg3OXk1RS1zc0drUFBPSXJ5WFVyVmZ4RXRVSG92Tk11cFJoVG5sdmFxZTNJdk4wNmQ1VTBGSnNUZ09fbXN4NGpRZEgxYUJzZURPclZ3WnFjNlhaclEwWXBCSGZqdC1QMzNaMXU?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart.com","headline":"Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | Delve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5CLVRlZVplRXVHVTVnWUpxTUNhWVBjMHFqRjlYQnpPbXROQ1pmXzBiXzlraXpzcDNwWGZFUmd3VWZLT05PdlI2N1d4UTlQUVdyV2prZkZmUmpIODNZMEhJ?oc=5","date":"2025-08-07","type":"trial","source":"Nature","summary":"The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial - Nature","headline":"The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized control","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOUFI2aXhqeDRCX2I5SlM2Zy1ndUpvZ19WZzFYcnNFM1o5bTNmRkVnRDNxSm1HYjJIWWJCTnZaSXgzZmFpd2VJUXotbnNMdlpBd3JhS2Q3Y2I0VUl4Q3pWMFlObGQ3RmFCQ1JtQkttbW1wZDNuMXpwRmU0ZEdIb2RKN2FYRHZsSjhma1JUTUpHT2h0cDBPMWs1Vk1BWTM3dTVDTVB5OEJQVGlMU25fcmxSRA?oc=5","date":"2025-07-18","type":"pipeline","source":"Yicai Global","summary":"China's Zenshine Gets Green Light to Sell New Anti-Flu Drug to Diversify Supply - Yicai Global","headline":"China's Zenshine Gets Green Light to Sell New Anti-Flu Drug to Diversify Supply","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxOVE85QlhZaUcxdWVBeHZGaHZxcWJ6N21naFV1cTFROExZRS1nRjRadnQwZWpfMlVJLTl0aW94VExXUkxDSDFfZEY5V01WLVVDSjJTS1lvbUJaWnBtQ2FDQXphODFXeEtUdjJRVHllUEp3WlpYQlluQWpuWlE3TWZmYnNJT0tSazY2OVprRS1BTV9VQzdQQnQ5d1RRVXpaSnJ4RjJRaXhoNkYzbURUMEFWeHZJZmhsRGdRUng4djFZUTNXVWd4b19fUDJxNnhkeTNWQ09kaVZIVk1zUTNNQm5DYTV6YzFnNFFhTnVrTEhjMmFwQzZXdjNTMHhSRTdsRkxhaVZhcXlZbm5YRU9uSHljc2VIQmNBWGpMSjlnb09WcTgtU0x2c0FUV0Y3aUc?oc=5","date":"2025-05-08","type":"pipeline","source":"GlobeNewswire","summary":"High- and Low-Grade Serous Ovarian Cancer Market is - GlobeNewswire","headline":"High- and Low-Grade Serous Ovarian Cancer Market is","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOT3V0UTc3SUE5NDZKYmcxR292V2pYcVhMWjlfaGRfZlpqYTlQYzhRd3RoNXI3N3doZU5ReEVoZmI4RUlBYkM2VWJwNnFWc2xwajk0eWp4RWJvWnZVS1NrRlJuOHlVX1BxQmZPWXMwWFRKWjBpU240ajlrUzNpcWpwR05RMUtycGNUMHZmOHRMWEtNS1NxLUxmNXJxWnlPREhkbThuS0RSSU15cWM5ZUJUam0zd3ZhOGJVaTB3TDl2WTlBMHFKNzZ1NDFpaXNUYzM2LWgtcUl4VHNNbm8yWVc1SVZTT1ota2ZJb3RZVGphY0hOR2FsZ1R5MWs4NVk3MEVYd1dWMk8xSEIwRUZJ?oc=5","date":"2025-04-24","type":"pipeline","source":"prnewswire.com","summary":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | DelveInsight - prnewswire.com","headline":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | Del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOMFc3aGVpRlJvcE1OcHFlb09EdjdKZlJ4ekExRWdSamNhVndjOVE3b1poazNoSDRTajUxVXJjdndNdEZfV3NZdTVhVWRPTmQwdk4tOTJUWWFLY25YZlR6eXVMU043bFVxQmVfaTB3ZTRMRG8ydmVERlMzdUUyUGdIWFU5S2FWNXBMOWNHVlR3?oc=5","date":"2025-04-01","type":"regulatory","source":"Yicai Global","summary":"China Approves Kerui Pharma's Next-Gen Influenza Drug - Yicai Global","headline":"China Approves Kerui Pharma's Next-Gen Influenza Drug","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2024-10-02","type":"regulatory","source":"GlobeNewswire","summary":"SERD Market is Predicted to Exhibit Remarkable Growth Owing - GlobeNewswire","headline":"SERD Market is Predicted to Exhibit Remarkable Growth Owing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZ1R2OG0yX293dnl5YVhwS3UtcmtBQ0wzaFFFMVZBcVA0TmFZQnFJUXNKYjBNVEJoMkE1dlFjcXRVRTNhSk8tLUgzZjl3MkJMZFJIOTV4QzdhVWJMUmtqZXQwai1QLXVqNk50cUF4TkJtaDlUOHdkaUFtM3Ixak4tYm5JRjl5VHVJaHloSFFYN25RTkM5S2NvOWlIT250bDA5MEloU2phQm5TZklCdEFzQ2c3ZGdfWHF0eThURTMyOW1LSXRzVGpOaENhWFBzVHNyRzlEamp1RU96bW5vZWc0?oc=5","date":"2024-09-25","type":"pipeline","source":"prnewswire.com","summary":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight - prnewswire.com","headline":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQbnFfbDU2Vlc0ZW9BcnItOVEta2p2eVBmM3FaaFFERG5CS0tRd2JBd2ZtWXNOd0lXMEZYNG55LS1SaF82T3ltWDFnV2JVQmQzODJjT0RHSGdDOS1LcGJzemZzV2I2cjI1NnVEV0FFSFBKQXhVT05xZlhQQmxWMGNzTjYyOUtnUHczRGdCaTlCQjdjZ3FpbTZyaXZDdktWeWVKc09feVNtbVc5bEVGS09PR29ZSk52Z0t3UkhvbHFDZ2UtWHh3YklxYk45RUo3c1UtOUVZX0FILVozU1MzZTFfREZaYmo1dw?oc=5","date":"2022-08-31","type":"pipeline","source":"prnewswire.com","summary":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight - prnewswire.com","headline":"Influenza Pipeline Looks Promising as 100+ Companies Working in the Domain, Assesses DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOdmtVN1c2UnVYSzhvTUpPSEg0NXJWdmp0Q3UwLTJ0dFozY21LTXk2U2pZQ3VGNzdGTlhVOWZrZnppdl9Bc29xSndxOE5Sbm9yc2F2N3ZFUmd2NUVmX0g0ZzhvSE5JeWxLbTlmZ2dPVGUwWFB6bXlKOGdvMW8wd1h0QkJMVUhoRUNCQ0tOWE1GZjlrYnpKS19vcmpQUQ?oc=5","date":"2020-04-21","type":"pipeline","source":"openPR.com","summary":"Worldwide Report on Entecavir Market By Growing Sector with - openPR.com","headline":"Worldwide Report on Entecavir Market By Growing Sector with","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}